Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials.

Dautzenberg, B; Levi, A; Adler, M; Gaillard, R

Dautzenberg, B; Levi, A; Adler, M; Gaillard, R.

Afiliação

Dautzenberg B; APHP Sorbonne University, Pitié-Salpêtrière Hospital, 75013 Paris, France; Institut Arthur Vernes, Smoking Cessation Unit, 75006 Paris, France. Electronic address: bdautz@gmail.com.
Levi A; Department of Psychiatry, Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neurosciences, 75014 Paris, France.
Adler M; Smoking Cessation Unit, Hôpital Antoine, Béclère APHP, 92140 Clamart, France.
Gaillard R; Department of Psychiatry, Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neurosciences, 75014 Paris, France; Université de Paris, 75006 Paris, France; Unité de Neuropathologie expérimentale, Département Santé Globale, Institut Pasteur, 75015 Paris, France.

Respir Med Res ; 80: 100844, 2021 Nov.

Article em En | MEDLINE | ID: mdl-34153704

Assuntos

COVID-19; Colite Ulcerativa; Humanos; Nicotina/efeitos adversos; não Fumantes; SARS-CoV-2

Palavras-chave

COVID-19; Clinical trial; Non-smoker; Side-effects; Transdermal nicotine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / COVID-19 Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Limite: Humans Idioma: En Revista: Respir Med Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google